OMLONTI Early Experience Program
Free trial from Ocuvex Therapeutics
Omlonti’s maker offers new patients a free trial. See its page for how to get it.
From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.
Generic name: omidenepag isopropyl
Used for: Glaucoma and high eye pressure
Ask for the cash price
Omlonti
We didn’t find one.
Details for each option
Free trial from Ocuvex Therapeutics
Omlonti’s maker offers new patients a free trial. See its page for how to get it.
From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.
There isn’t one. An authorized generic is Omlonti itself, from the same company, sold without the brand name, and usually for less. For now Omlonti is the only choice; its maker’s savings card can lower what you pay.
We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.
Omlonti (omidenepag isopropyl ophthalmic solution) 0.002%, is a relatively selective prostaglandin E2 (EP2) receptor agonist, indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Source: the FDA label for Omlonti (Ocuvex Therapeutics, Inc.), April 21, 2025. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/omlonti/